Drawing for GENFIT TOWARDS BETTER MEDICINE

USPTO serial 87401101

GENFIT TOWARDS BETTER MEDICINE

Reviewed by CopyMark Law Group

Reg. 5399953Status 702Registered
Filing date
Status date
Registration date
Feb 13, 2018
Examiner
MURRAY, GEORGE WILLIAM
Law office
TMO LAW OFFICE 121

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with GENFIT TOWARDS BETTER MEDICINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ronald M. Kachmarik

Ronald M. Kachmarik Cooper Legal Group LLC1388 Ridge Road, Unit 1Hinckley, OH 44233UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; cultures of microorganism for medical, pharmaceutical or veterinary use; cells preparations for medical, pharmaceutical or veterinary use, in particular for gene therapy or cell therapy; diagnostic preparations for medical or veterinary purposes; diagnostic reagents for medical or veterinary use; sanitary preparations for medical use; dietetic foodstuffs for medical use; food supplementsACTIVE—
042Pharmaceutical research, namely, research for the discovery of new drugs; scientific research, in particular in the medical, biomedical, chemical, genetic, pharmaceutical and veterinary fields; basic and applied scientific research; technical research in the field of pharmaceutical studies; screening and selection of molecules for scientific research purposes; development and validation of biological tests, of cell tests and of genetic tests; Functional analysis of genomics to identify, characterize, validate or develop biologically active molecules; analysis of biological substances in biologic fluids; computer programming in the field of scientific research and for the pharmaceutical industry; engineering surveying; analysis of technical projects; professional consultancy, not connected with the conduct of business, in the field of scientific research; research and development of new pharmaceutical products for third parties; scientific research in the field of pharmacyACTIVE—
044Professional consultancy, not connected with the conduct of business, in the field of hepatology, gastroenterology, cholestatic, cardiovascular, metabolic, inflammation, autoimmune therapyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 5, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
May 4, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
May 4, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 6, 2023E815TEAS SECTION 8 & 15 RECEIVED—
Feb 13, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 13, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 28, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 28, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 8, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 26, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 20, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 16, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 16, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 11, 2017ALIEASSIGNED TO LIE—
Sep 28, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 25, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 25, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 25, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 25, 2017DOCKASSIGNED TO EXAMINER—
Apr 14, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Apr 13, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 10, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance